Comments (130)

Aug 4, 2021 - 4:10pm
Deter6895, what's your opinion? Comment below:

Trust me, I've complained several times to upper management and more loudly to my fellow junior analysts. Mgmt said it was being considered in June. Still holding out hope for a larger than usual raise come bonus time, but I'm beginning to lose hope.

Aug 15, 2021 - 11:57am
TheFlyingKiwi, what's your opinion? Comment below:

What type of bank are you at? BB, MM, boutique?

Go all the way

Aug 4, 2021 - 7:23pm
Deter6895, what's your opinion? Comment below:

Why? Record profits in markets, IB, and credit losses best they've been in 20+ years. Why should I be happy there aren't salary reductions when business is better than ever? 

  • Business School in IB - Cov
Aug 4, 2021 - 7:32pm

Bro his name is literally losingalpha

Aug 4, 2021 - 10:17pm
dickthesellsider, what's your opinion? Comment below:

Sure, but here is how a bank's senior executive views equity research:

Revenue: $0

Cost: salary + bonus + other opex

Profit: negative of (salary + bonus + other opex)

Hence, be glad they are reducing salary / laying off, or forcing the same headcount to cover more stocks, or shutting down the department altogether. 

Aug 8, 2021 - 10:56pm
YungMonc, what's your opinion? Comment below:


Why? Record profits in markets, IB, and credit losses best they've been in 20+ years. Why should I be happy there aren't salary reductions when business is better than ever? 

Because ER is not markets or IB. It's a cost center like the India office that fixes your iPhone when it's got a glitch. It will be automated soon. 

  • Intern in HF - EquityHedge
Aug 8, 2021 - 8:45pm

Heard jpm increased research guys to 100k. That's a start at least.

Aug 13, 2021 - 2:25am
Smoke Frog, what's your opinion? Comment below:

Equity research is considered like credit, the red headed step child. Your base adjustments will always lag IB and your bonuses will never catch up.Think about it this way, IB brings in revenue and many times that success is incumbent on the relationships the bankers have with clients.Equity research is something anyone can do, you don't need a relationship with companies. And you don't bring in any revenue. Similar story to credit, which is probably even more useless considering every bank I've worked at never turns down a deal lol.

EDIT: man the research guys don't like the cold hard truth lol.

Aug 13, 2021 - 1:14pm
researchguy1234, what's your opinion? Comment below:

Yikes. Clearly you know literally nothing about ER whatsoever as the other poster said. I'm not even on the sell side anymore yet I feel compelled to defend it from rampant misinformation like this. 

Yeah, pay is lower than IB, but it's still pretty damn high for a young professional and you don't get treated like a slave (which is the impression I get from IB) AND the work is actually interesting / challenging even at the most junior levels. If we were expected to work 80-100 hrs a week, the pay gap would be narrower. Why would banks keep supporting and investing in their research franchises if they added no value, served no purpose, or could be replaced by 'anybody' cheaper? Think about that…banks try to maximize profit like any other company. 

Relationships (with the companies, investors & KOLs) are also absolutely critical if you're on a good team as well. Also, research does generate revenue, both directly (fees) and indirectly (trading), albeit less than IB and at lower margins. The reason this still works is because research also generates synergies with other business units like IB, wealth management, trading, etc. that help those business make more money. Note that not every bank does this the same way so I am generalizing to an extent. 

Aug 13, 2021 - 2:17pm
Smoke Frog, what's your opinion? Comment below:

I know I come off as harsh sometimes, but it's a forum not a dinner party so why try to be polite instead of telling the harsh truth.

Equity research is where people who couldn't get into banking go or people who want to eventually move into banking but can't get in at first.

Equity research is like a nice to have, there is a reason the pay sucks. Is it a good job compared to regular jobs? Sure, but we are talking about elite places on this forum. Don't try to justify the low pay, just be honest man.

The OP asked my ER pay is lagging. It's cause you don't pay the second tier people, that's why.

It's like saying duke isn't that good a school. It's better than most, but it's no Ivy League. Keep it real man.

  • Research Associate in ER
Aug 13, 2021 - 2:57pm

Agree to disagree, but your comments come off extremely insecure rather than harsh. It's one thing to point out differences in function and another thing to get into a dick measuring contest about prestige and tiers when nobody asked. I hope you don't tie your entire life's self-worth on things like this, but then again it's WSO, so can't expect much. Cheers.

Aug 13, 2021 - 3:13pm
Smoke Frog, what's your opinion? Comment below:

I'm keeping it real in case a young person reads this and is considering research vs banking and thinks research isn't that bad after reading this. I don't understand what I am saying that is so controversial. The OP asked my ER isn't getting bumps and I said because its not a very vital function. I don't understand how that rankles people. The banks or any company pays the jobs it values the most. That's why surgeons are typically paid more than general practitioners right? IB is paid better than ER because the job is tougher and requires more talent. The pay reflects this.

I had a short stint in credit, and I am telling you the people I worked with were not as bright or motivated. Hence, the lower pay. Also, there is a plethora of equity research reports out there, plus rating agency reports, etc so the work literally is fungible.

Again, all I said was ER bases lag because its not a sexy or high powered sector in a bank. I don't understand how this bothers so many people.

Most Helpful
  • Research Associate in ER
Aug 13, 2021 - 3:35pm

Thanks for elaborating on your stance. I don't think anyone would disagree with you in saying IB generates more direct revenue than ER. That said, it's another thing to make a blanket statement that people in ER aren't as "talented" as those in IB and can be easily replaced - I think it's this mindset that irks most people here. I fundamentally disagree with you on this point, and think it's terribly misleading for you to say that with the amount of young people coming here for career advice. I really don't see how an IB associate is any less replaceable than an ER associate, since most of junior IB work is just modelling/ppt. Top ER analysts also have better industry knowledge than IB MDs, and I've seen them shift to senior IB roles easily.

Personally, I chose ER because I find it more intellectually stimulating, and have plenty of friends in IB BB/buy-side. I don't see a difference in talent or intelligence, and my exit ops look just as cheery. Again, the caveat is to pick a 'hot' sector rather than a dying one, and work for a good analyst.

And to your analogy, just because someone is a surgeon doesn't mean they are more talented than general practitioners - most of the times it's a personal choice. I think I can say with confidence because I'm one of those ex-medical professionals who went into finance.

  • Intern in HF - EquityHedge
Aug 13, 2021 - 2:58pm

Dont think anyone here cares or is hurt from your "harsh tone". Your characterization of the job is just wholly incorrect and definitely shows you have some insecurities. Most people going to research likely arent considering IB anyways, and most exits from research are directly to the buyside or staying within research - Not IB.

Look, if you have the need to feel superior to others, dont know why you havent exited to a position that provides way more interesting work and skin in the game - then you could look down on bankers too. Sellsiders might not be value adds, but bankers seldom are either - much more show than substance.

Dec 4, 2021 - 3:56pm
gringo, what's your opinion? Comment below:

I would never do banking at a junior level regardless of pay or what you view as "prestige". You do realize how mind numbing the job is? I think you fail to realize that you're not getting paid because of your expertise but b/c you're willing to be sb bitch. 

  • Research Associate in ER
Aug 13, 2021 - 12:05pm

I say this is more sector dependent. If we're using pay as a benchmark on value add, just look at how much biotech/HC analysts are getting paid.

For the record, as an associate, I'm getting the same base as IB associates at my bank, but that's because of the sector I'm in and related experiences. To each their own.

  • Intern in IB - Gen
Aug 13, 2021 - 1:16pm

Love to see it. Hopefully some of the small shops/boutiques follow suit (though not necessarily likely, no idea what theyre thinking rn)

Mar 1, 2022 - 10:49am
ERanonymous, what's your opinion? Comment below:

A little delayed on my end, but did you hear what the raises were at Stifel? Wondering as I have not heard anything on this.

Aug 13, 2021 - 1:28pm
imnotwacc, what's your opinion? Comment below:

The number of people saying ER brings in no revenue just shows how little people actually know about ER. Basically every ER dept in a major US bank brings in revenue under MiFID-II lol. And in the sell-side, ER also gets paid by IB for every IPO ER is staffed on.

Aug 13, 2021 - 1:48pm
losingalpha, what's your opinion? Comment below:

ER can't be paid with banking revenue so I'm not sure what you're talking about here. It's a cost center for most banks and most banks are letting that group go. 

Aug 13, 2021 - 2:20pm
researchguy1234, what's your opinion? Comment below:

While ER compensation cannot be tied to specific deals, analyst bonuses can be based on 'broad value add to firm' which includes involvement in deals. This is how they get paid for being tied to deals without stating it explicitly, and is one of the reasons sectors like biotech get paid more (ie lots of deal activity to support them). At many banks, ER does play an important role to the overall service to corporate clients (including simply providing coverage for the issuer, which is important). 

Not sure what is with the vendetta against ER from some users on here who know nothing about it, but it's very strange. 

Nov 16, 2021 - 5:45pm
GaribaldiIV, what's your opinion? Comment below:

On an income statement, the ER segment would definitely look like a net cost. But the coverage ER provides to companies that do deals with the bank can be a big deciding factor for those companies, driving some IB revenue indirectly. ER also drives market activity with new information, views, and buy/sell calls, and this can trickle into S&T activity for the bank. At some banks, subscription fees actually cover the cost of the entire research department. Moreover, I think you'll see bank customers expecting high quality research and investment ideas as IBs begin to manage more money and deal flow continues, so I think the outlook for the sector is favorable.

  • Associate 1 in RE - Comm
Sep 11, 2021 - 4:42pm

Take your beady little er eyes and shut the fuck up

  • Intern in IB - Gen
Aug 15, 2021 - 6:26pm

The only reason that ER will lag IB is because you work less hours.

Until you reach the MD/VP levels (which 1% of analysts do anyway in IB or ER), you could say both are a cost center. I don't know how you could disagree on the fact that MDs in ER add value. Most of them are on CNBC all the time, constantly interacting with buyside clients, and providing valuable research to bankers for their firm's own deals.

The only difference is that junior IB analysts work 40% more so their bonus will account for that. People have been saying for the past 20 years that ER will fade away - yet all the automation and S&T job cuts we haven't seen any major bank cut ER (Nomura doesn't count since they just acquired Wolfe and dropped their own brand - offsets).

For what it's worth, my salary in ER as a junior analyst is the EXACT same as IB.

Aug 16, 2021 - 10:41pm
losingalpha, what's your opinion? Comment below:

Bullshit. Comp for juniors in ER should never be equal to revenue generating groups like IB. It's more believable if you're a few years into ER and comparing yourself to a 1st year analyst in IB

Oct 13, 2021 - 12:18am
dundermifflin107, what's your opinion? Comment below:

LOL so wrong....I've been in the market recently and have received senior associate offers (e.g., 3-6 YOE) for II ranked ER teams in hot sectors (e.g., TMT) that promised a range of ~$250-350K all in. This is contingent on a ~55-65 hour work week on avg., so the per hour compensation is roughly comparable to what IB associates make after doing 80+ hour weeks

  • Intern in IB - Cov
Mar 26, 2022 - 9:43am

Lol Number monkey second year analyst at IB got mad cuz only thing he does is model and get treated like shit. Zero client interaction. Just aligning stupid decks and plugging small numbers into your model doesn't generate revenue for the bank.

Most ER associates gets client interaction from year 1 and gets significantly deep fundamental understanding of the sector.

Aug 24, 2021 - 10:04pm
ArchBrand001, what's your opinion? Comment below:

Comp definitely going up across the board at most firms (not by any amount worth crying over at the junior level) that aren't already doomed. But a word of wisdom to those seeing the golden goose (ridiculous bids from competing firms) being dangled in front of them - make sure you choose the right ship to jump to... it's almost inevitable that this boom period in comp/hiring is temporary and will result in headcount/bonus cuts in a a couple of years at a significant number of shops once the pipeline dries up.

  • Analyst 1 in ER
Sep 4, 2021 - 10:13pm

Correct me if I am wrong, but isn't BoA raising to $100k only a rumor so far? I know there was news on it but nothing official

  • Prospect in ER
Sep 11, 2021 - 4:17pm

First year at JPM research and still have not heard about a raise... base still at 85k... are we getting the raise or nah?

Feb 1, 2022 - 10:39am
VanHalenAM, what's your opinion? Comment below:

They've raised them at BofA to a base of 100k.

Source: SA

Go ahead and JUMP!

Feb 1, 2022 - 7:41pm
Jalaid14, what's your opinion? Comment below:

Do you know comps of associates (with 3-5 years of experience), or can share the source link? Thanks. 

Feb 1, 2022 - 7:45pm
VanHalenAM, what's your opinion? Comment below:

I don't know the compensation for associates with 3-5 years of experience, but my source is that I got an email from BAML stating that they have increased base salaries from 85k to 100k for ER and that I needed to sign an updated form for my upcoming summer analyst internship.

Go ahead and JUMP!

  • Analyst 1 in ER
Feb 27, 2022 - 5:38pm

How come every other post and personal sources in IB are saying 110/115? Is this exclusively research? Why are they getting a higher base than banking?

  • Intern in IB - Cov
Mar 26, 2022 - 9:37am

London MM banks bumped base for first year equity research associates/analysts to 60-65k GBP with 50-70% bonus (tech and healthcare more higher than other groups). London BB Equity Research seems to be around 70-75k GBP with around 50% bonus. Hope London pay catches up with the US like the old days when pound was strong.

Time to jump around if other firms offer higher pay

  • Analyst 2 in ER
Apr 1, 2022 - 12:55am

I genuinely feel that the recent couple years really really screwed ER over. Hiring is through the roof so headcount is being added but many teams are extremely understaffed in the meantime as recruiting takes forever. Then ER is basically holding the short end of the stick and receiving comp increases vastly slower than IB and that's not even mentioning the bonuses. Firms are talking about record demand, record revenue and yet are giving nothing in return. 

Anyhow my quick rant and why I am trying hard to switch out. 

Apr 29, 2022 - 5:58am
xtrapig, what's your opinion? Comment below:

MM Year 2 Associate in Research- base: 60k unchanged YoY (absolute shit show, considering rising inflation, negative growth)- base: 3 months

Jun 9, 2022 - 8:59am
xtrapig, what's your opinion? Comment below:

Est modi illum exercitationem. Consequuntur minima enim ut eius dolorum tenetur. Sequi omnis perferendis culpa. Id et laudantium omnis eos ad libero. Ab sed numquam est.

Laborum non dignissimos voluptas quis nihil blanditiis. Minus omnis et perspiciatis eius officiis commodi odio. Voluptates praesentium dolorem inventore. Rem explicabo ut ipsum quia aut.

Ea magnam omnis qui quidem et eos aliquid. Dolorem ut earum quis. Et delectus enim et earum rem. Non tempora ut laboriosam sint ex. Non ut consequatur eos reprehenderit. Labore ipsum autem aut. Quo voluptatem at labore fugit quidem.

Non laudantium illum omnis. Rem minus rerum sunt doloremque aliquam quas sit. Atque officiis ullam qui doloribus.

  • Prospect in ER
Jun 3, 2022 - 10:54pm

Aperiam laboriosam mollitia hic voluptatem ab soluta. Possimus qui distinctio autem dolores sunt architecto quidem quidem. Delectus non debitis nemo voluptatem vel quo qui.

Nam voluptatem ducimus veritatis numquam et dicta minima. Maiores et quia earum libero voluptatem. Perferendis nam accusantium sequi quia porro. Rerum velit libero modi consequatur voluptas alias.

Officia officia assumenda labore laborum. Et a quia alias provident numquam quo aut molestiae. Et temporibus voluptas enim esse doloribus quaerat fugit. Est aut quos libero qui aut et. Et error quia esse et. Ut facere consectetur harum molestiae aut aut molestiae.

Ratione eaque incidunt suscipit omnis. Magni saepe velit id esse.

Jun 29, 2022 - 7:35pm
shortsquuze, what's your opinion? Comment below:

Velit voluptate nesciunt voluptatum dolor voluptate non. Consequatur blanditiis cumque maiores sed quod optio dolorem. Velit porro porro in iusto recusandae. Velit esse modi voluptas aut dolore consequatur minima.

Possimus error qui eum laborum. Et illum corporis nihil quas. Voluptatem aut sed earum velit deleniti modi. Non exercitationem repellendus sequi omnis nihil. Rem quod voluptatem dolores. Ipsam adipisci eos dicta libero voluptas consequuntur esse. Soluta est id culpa.

Nihil nihil molestiae omnis tempore aperiam cum labore. Nihil explicabo sapiente ratione provident ratione et. Expedita qui placeat quaerat porro vitae.

Start Discussion

Career Advancement Opportunities

July 2022 Investment Banking

  • Jefferies & Company (▲03) 99.6%
  • Lincoln International (= =) 99.2%
  • RBC Capital Markets (▲07) 98.8%
  • Bank of America Merrill Lynch (▲01) 98.4%
  • Houlihan Lokey (▲06) 98.0%

Overall Employee Satisfaction

July 2022 Investment Banking

  • Lincoln International (▲06) 99.6%
  • Jefferies & Company (▲11) 99.2%
  • Greenhill (▲07) 98.8%
  • Rothschild (▲01) 98.4%
  • Evercore (▽01) 98.0%

Professional Growth Opportunities

July 2022 Investment Banking

  • Jefferies & Company (▲04) 99.6%
  • Lincoln International (▲04) 99.2%
  • RBC Capital Markets (▲09) 98.8%
  • Houlihan Lokey (▲07) 98.4%
  • Bank of America Merrill Lynch (▲04) 98.0%

Total Avg Compensation

July 2022 Investment Banking

  • Director/MD (9) $661
  • Vice President (37) $394
  • Associates (191) $246
  • 2nd Year Analyst (117) $162
  • 3rd+ Year Analyst (17) $156
  • 1st Year Analyst (369) $150
  • Intern/Summer Associate (78) $147
  • Intern/Summer Analyst (292) $92